Role of chronic and acute hyperglycemia in the development of diabetes complications

Diabetes Technology and Therapeutics

Volumn 13, Issue 3, 2011, Pages 389-394

  Marcovecchio, M Loredana ^a   Lucantoni, Marta ^a   Chiarelli, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSIN II; DIACYLGLYCEROL; GLUCOSE; HEMOGLOBIN A1C; HEXOSAMINE; PROTEIN KINASE C;

ACUTE DISEASE; CHRONIC DISEASE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; TISSUE INJURY;

BLOOD GLUCOSE; DIABETES COMPLICATIONS; HUMANS; HYPERGLYCEMIA; RISK FACTORS;

EID: 79952136181     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0146     Document Type: Review

References (51)

1. Sheetz MJ, King GL: Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579-2588. (Pubitemid 35386893)
2. Mokini Z, Chiarelli F: The molecular basis of diabetic microangiopathy. Pediatr Endocrinol Rev 2006-2007;4:138-152. (Pubitemid 46383868)
3. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053. (Pubitemid 38579764)
4. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787. (Pubitemid 34000780)
5. Daneman D: Type 1 diabetes. Lancet 2006;367:847-858. (Pubitemid 43363372)
6. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G: Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033.
7. Bryden KS, Dunger DB, Mayou RA, Peveler RC, Neil HA: Poor prognosis of young adults with type 1 diabetes: a longitudinal study. Diabetes Care 2003;26:1052-1057. (Pubitemid 36929247)
8. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412. (Pubitemid 30609442)
9. International Diabetes Federation: Diabetes Atlas. Brussels: International Diabetes Federation. www.eatlas.idf.org/ (accessed October 2, 2010).
10. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820. (Pubitemid 34000785)
11. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R: Diabetic retinopathy. Diabetes Care 1998;21:143-156. (Pubitemid 28030402)
12. Deshpande AD, Harris-Hayes M, Schootman M: Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008;88:1254-1264.
13. Bloomgarden ZT: Diabetic retinopathy. Diabetes Care 2008; 31:1080-1083.
14. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta: Centers for Disease Control and Prevention, 2005. www.cdc.gov/diabetes/ pubs/pdf/ndfs-2005.pdf (accessed October 2, 2010).
15. Candrilli SD, Davis KL, Kan HJ, Lucero MA, Rousculp MD: Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complications 2007;21:306-314. (Pubitemid 47354231)
16. Verrotti A, Loiacono G, Mohn A, Chiarelli F: New insights in diabetic autonomic neuropathy in children and adolescents. Eur J Endocrinol 2009;161:811-818.
17. Ceriello A: Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005;54:1-7. (Pubitemid 40105088)
18. Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-240. (Pubitemid 29056916)
19. Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M: Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 2008; 31(Suppl 2):S155-S160.
20. Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Yano K, Curb JD: Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care 1999;22:1262-1265. (Pubitemid 29350234)
21. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-267. (Pubitemid 26070354)
22. Singh R, Barden A, Mori T, Beilin L: Advanced glycation end-products: a review. Diabetologia 2001;44:129-146. (Pubitemid 32156196)
23. Humpert PM, Kopf S, Djuric Z, Wendt T, Morcos M, Nawroth PP, Bierhaus A: Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes. Diabetes Care 2006;29:1111-1113. (Pubitemid 44115254)
24. Tahara Y, Shima K: The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care 1993;16:1313-1314. (Pubitemid 23259881)
25. American Daibetes Association: Standards of medical care in diabetes-2008. Diabetes Care 2008;31(Suppl 1):S12-S54.
26. Gillett MJ: International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334. Clin Biochem Rev 2009;30:197-200.
27. Herman WH, Fajans SS: Hemoglobin A1c for the diagnosis of diabetes: practical considerations. Pol Arch Med Wewn 2010;120:37-40.
28. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk ofcomplications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
30. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE: Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-278. (Pubitemid 41079621)
31. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167.
32. Bode BW: Defining the importance of daily glycemic control and implications for type 2 diabetes management. Postgrad Med 2009;121:82-93.
33. Giugliano D, Ceriello A, Esposito K: Glucose metabolism and hyperglycemia. Am J Clin Nutr 2008;87:217S-222S.
34. Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care 2003;26:881-885. (Pubitemid 36929359)
35. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW: Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25:1845-1850. (Pubitemid 41071098)
36. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 2001;322:15-18. (Pubitemid 32066250)
37. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, Kronmal RA, Resnick HE, Psaty BM: Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 2002;162:209-216. (Pubitemid 34098191)
38. Gerich JE: Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 2003;163:1306-1316. (Pubitemid 36676195)
39. Yamagishi SI, Nakamura K, Matsui T, Ueda SI, Imaizumi T: Role of postprandial hyperglycaemia in cardiovascular disease in diabetes. Int J Clin Pract 2007;61:83-87.
40. DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405.
41. Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A: Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 2005; 112:179-184. (Pubitemid 40982299)
42. Gordin D, Forsblom C, Ronnback M, Groop PH: Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes. Diabet Med 2008;25:101-105.
43. Gordin D, Ronnback M, Forsblom C, Heikkila O, Saraheimo M, Groop PH: Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia 2007;50:1808-1814. (Pubitemid 47222850)
44. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-983.
45. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
46. Choi SW, Benzie IF, Ma SW, Strain JJ, Hannigan BM: Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med 2008;44:1217-1231.
47. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D: Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008;57:1349-1354.
48. Nalysnyk L, Hernandez-Medina M, Krishnarajah G: Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab 2010;12:288-298.
49. Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-1490. (Pubitemid 44127568)
50. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH: Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008;51:183-190. (Pubitemid 50002199)
51. Kumareswaran K, Evans ML, Hovorka R: Artificial pancreas: an emerging approach to treat Type 1 diabetes. Expert Rev Med Devices 2009;6:401-410.